Evidence map›Paper›PMID 40552640›Full record

ArticleJournal of cosmetic dermatology2025

The Reduction of Skin Photodamage by the Ectoine-Thermus thermophilus Cofermentation Products.

Yiyu Wang, Jiayi Liang, Pengkun Zhang, Guihui Yan, Hui Jiang, Meijing Wang

Abstract read
In one paragraph

Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yiyu WangHangzhou Sanshi Cosmetics Co. Ltd, Hangzhou, China.
Jiayi LiangCollege of Life Sciences, Zhejiang University, Hangzhou, China.
Pengkun ZhangUmotor Biological Technology Co. Ltd, Hangzhou, China.
Guihui YanUmotor Biological Technology Co. Ltd, Hangzhou, China.
Hui JiangCollege of Life Sciences, Zhejiang University, Hangzhou, China.
Meijing WangCollege of Life Sciences, Zhejiang University, Hangzhou, China.

Funding

Zhejiang Provincial Natural Science Foundation of China LTGY23C010002
6 · The paper itself

Abstract

backgroundProlonged exposure to UVB (280-320 nm) can lead to skin oxidative damage, inflammatory response, and skin cancer. Many active ingredients in the fermentation products of Thermus thermophilus have been shown to play important roles in antioxidant and anti-UVB photodamage, such as superoxide dismutase (SOD) and photolyase. Ectoine, as one of the most prevalent compatible solutes in halophilic bacteria, can protect cells, proteins, cell membranes, and nucleic acids from external extreme environments such as high temperature, freezing, irradiation, and drying. It has been applied in the industries of fine chemicals, biomedicine, and biomanufacturing worldwide.

aimsIn this study, we evaluated the antioxidant activities and anti-UVB photodamage activities of Ectoine-T. thermophilus cofermentation products (D-Ectoine).

methodsThe comparison between D-Ectoine and Ectoine was analyzed with hydroxyl radical (OH·

resultsThe results showed that D-Ectione could promote the GSH-PX activity in HSF cells with stronger T-AOC and DPPH scavenging capacity, reduce the expression of LPS-induced inflammatory factors IL-6 and IL-8, increase Col I expression both with and without UVB and inhibit expression of MMP-1 after UVB irradiation. In the 3D skin model, D-Ectione could increase the number of cell survival and Nrf2 expression, and decrease 8-OHdG expression after UVB irradiation.

conclusionsThese results demonstrated that D-Ectione has protective effects against UVB-induced skin photodamage and may contribute to the development of cosmetic products with anti-UVB.

Indexed as

Amino Acids, DiaminoAntioxidantsSkin AgingUltraviolet RaysFermentationFibroblastsHumansOxidative StressSkinAmino Acids, DiaminoAntioxidantsectoineanti‐inflammatoryfibroblastsmicroorganismsphotodamageultraviolet

Identifiers

PMID40552640
PMCPMC12186289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.